Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

DRAD:US

4.3100 USD 0.0100 0.23%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Digirad Corp (DRAD)

Open: 4.2700 Day's Range: 4.0350 - 4.3200 Volume: 21,048
Previous Close: 4.3000 52wk Range: 3.1100 - 5.4800 1-Yr Rtn: +32.75%

Stock Chart for DRAD

No chart data available.
  • DRAD:US 4.3100
  • 1D
  • 1M
  • 1Y
4.3000
Interactive DRAD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRAD

Current P/E Ratio (ttm) 25.1854
Estimated P/E(12/2015) -
Relative P/E vs. SPX 1.3406
Earnings Per Share (USD) (ttm) 0.1711
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 82.94
Shares Outstanding (M) 19.24
30 Day Average Volume 37,268
Price/Book (mrq) 2.3460
Price/Sale (ttm) 1.4232
Dividend Indicated Gross Yield 4.64%
Cash Dividend (USD) 0.0500
Dividend Ex-Date 05/11/2015
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRAD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DRAD

Digirad Corporation develops, manufactures, and distributes solid-state medical imaging products. The Company's products and services are used for the detection of cardiovascular disease and other medical conditions.

Matthew G MolchanPresident/CEOJeffry R KeyesCFO/Secretary
Virgil J LottPres:Diagnostic ImagingMartin B ShirleySenior VP:Sales & Marketing
More Company Profile & Key Executives for DRAD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil